
SciSure helps scientific organizations replace fragmented, disconnected systems with a single governed platform for managing lab operations, so teams spend less time reconciling data across tools and more time on research. By combining Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and Health & Safety (EHS) capabilities in one system, SciSure improves reproducibility, strengthens visibility into day-to-day lab activity, and helps organizations reduce risk as they scale. Researchers document experiments, protocols, and results in a structured, searchable digital format with customizable templates and version control, replacing paper notebooks and scattered files. Samples are tracked from intake through processing, storage, and disposal, maintaining full lineage and chain-of-custody records alongside chemical and general lab inventory management and workflow automation. Health & Safety functionality is built into the same platform, covering chemical inventory alongside Safety Data Sheets (SDS), regulatory compliance workflows, and audit readiness, so labs don't need a separate system to stay compliant and audit-ready.
Labs can also extend the platform through an optional marketplace of add-ons, so they can bring in additional capability, like AI-powered support, automated data analysis, protocol generation, toxicity prediction, and image analysis, only where it adds value, without disrupting the rest of their workflow or committing to features they don't need. SciSure also connects directly to lab instruments, external databases, and third-party tools, so data moves between systems without manual re-entry.
SciSure supports both cloud and dedicated hosting, giving organizations control over the deployment model that fits their infrastructure, security, and compliance requirements. It's built to serve academic institutions, biopharma and biotech companies, and start-ups alike, with role-based support for scientists, lab operations staff, safety and compliance teams, leadership, and IT professionals, so the platform works the way each type of user actually needs it to.
Learn more
Revaly is a Payment Performance Management platform designed to ensure that every legitimate transaction succeeds, protecting the recurring revenue businesses depend on. It uses exclusive issuer signals, network intelligence, and AI-powered optimization to maximize payment approvals across the entire lifecycle. By preventing avoidable failures at the first attempt and intelligently recovering declined payments, Revaly reduces involuntary churn and strengthens customer relationships. The platform continuously analyzes routing errors, behavioral patterns, and ecosystem signals to turn unpredictable payments into predictable revenue. Subscription-based companies rely on Revaly to lift approval rates and compound revenue growth without disrupting their existing billing stack. With over 100 integrations, the system fits seamlessly into current workflows while delivering measurable, long-term financial impact.
Learn more
Iktos
Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO). It enables the design of novel and easy-to-make compounds in line with a multi-objective blueprint with unprecedented speed, performance, and diversity. Makya offers multiple generative algorithms covering different use cases from hit discovery to lead optimization: fine-tuning generator to find optimal solutions within your chemical space in line with your project blueprint; novelty generator to find new ideas with high novelty for re-scaffolding/hit discovery; forward generator to design a focused library of compounds easily accessible from commercial starting materials. The new Makya 3D module enhances the user experience and scientific utility of Makya. With an extensive set of 3D modeling features in both ligand-based and structure-based pipelines, with Makya 3D you can now calculate 3D scores and use these to guide generations natively in Makya.
Learn more